BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27999963)

  • 1. Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system?
    Jafarpour A; Dehghani F; Korf HW
    Cell Tissue Res; 2017 Apr; 368(1):115-123. PubMed ID: 27999963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes.
    Yasuo S; Koch M; Schmidt H; Ziebell S; Bojunga J; Geisslinger G; Korf HW
    Cell Tissue Res; 2010 Apr; 340(1):127-36. PubMed ID: 20165884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid hydrolase and cannabinoid receptor 1 are involved in the regulation of hypothalamus-pituitary-adrenal axis in type 2 diabetes.
    Luo Q; Chen S; Deng J; Shi L; Huang C; Cheng A; Liu W; Fang J; Tang L; Geng Y; Chen Z
    Metab Brain Dis; 2018 Oct; 33(5):1483-1492. PubMed ID: 29948652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways to and from the hypophysial pars tuberalis, an important center for the control of seasonal rhythms.
    Korf HW
    Gen Comp Endocrinol; 2018 Mar; 258():236-243. PubMed ID: 28511899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of an endocannabinoid system in the hypophysial pars tuberalis and pars distalis of man.
    Yasuo S; Unfried C; Kettner M; Geisslinger G; Korf HW
    Cell Tissue Res; 2010 Nov; 342(2):273-81. PubMed ID: 20957495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress.
    Surkin PN; Gallino SL; Luce V; Correa F; Fernandez-Solari J; De Laurentiis A
    Psychoneuroendocrinology; 2018 Jan; 87():131-140. PubMed ID: 29065362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis.
    Hillard CJ; Beatka M; Sarvaideo J
    Compr Physiol; 2016 Dec; 7(1):1-15. PubMed ID: 28134998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
    Rivera P; Luque-Rojas MJ; Pastor A; Blanco E; Pavón FJ; Serrano A; Crespillo A; Vida M; Grondona JM; Cifuentes M; Bermúdez-Silva FJ; de la Torre R; de Fonseca FR; Suárez J
    Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mimecan in pituitary corticotroph cells may regulate ACTH secretion and the HPAA.
    Ma QY; Zhang XN; Jiang H; Wang ZQ; Zhang HJ; Xue LQ; Chen MD; Song HD
    Mol Cell Endocrinol; 2011 Jul; 341(1-2):71-7. PubMed ID: 21664248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids and the Endocrine System in Health and Disease.
    Hillard CJ
    Handb Exp Pharmacol; 2015; 231():317-39. PubMed ID: 26408166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
    Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
    Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex.
    Blanco E; Pavón FJ; Palomino A; Luque-Rojas MJ; Serrano A; Rivera P; Bilbao A; Alen F; Vida M; Suárez J; Rodríguez de Fonseca F
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice.
    Torres LH; Balestrin NT; Spelta LEW; Duro SO; Pistis M; Marcourakis T
    Toxicol Lett; 2019 Mar; 302():35-41. PubMed ID: 30553937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases.
    Moreno-Martet M; Mestre L; Loría F; Guaza C; Fernández-Ruiz J; de Lago E
    Neurosci Lett; 2012 Feb; 508(2):67-72. PubMed ID: 22206832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of chronic central administration of corticotropin-releasing factor on food intake, body weight, and hypothalamic-pituitary-adrenocortical hormones.
    Hotta M; Shibasaki T; Yamauchi N; Ohno H; Benoit R; Ling N; Demura H
    Life Sci; 1991; 48(15):1483-91. PubMed ID: 1849215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
    Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
    J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.